Page last updated: 2024-08-22

monoethylglycinexylidide and Hepatitis

monoethylglycinexylidide has been researched along with Hepatitis in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (66.67)	18.2507
2000's	2 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Shaw-Stiffel, TA; Ziebell, J	1
Contos, MJ; Duckworth, PF; Edinboro, LE; Luketic, VA; Mills, AS; Poklis, A; Purdum, PP; Sanyal, AJ; Shiffman, ML	1
Deng, JF; Huang, YS; Lee, SD; Lin, YF; Lo, KJ; Lu, RH; Wang, YJ; Wu, JC	1
Fisher, RA; Luketic, VA; Posner, MP; Purdum, PP; Sanyal, AJ; Shiffman, ML	1
Botta, F; Giannini, E; Romagnoli, P; Testa, R	1
Ishii, T; Kaneko, H; Katagiri, M; Maeda, T; Otsuka, Y; Shiba, T; Takagi, S; Tamura, A; Tsuchiya, M	1

Trials

1 trial(s) available for monoethylglycinexylidide and Hepatitis

Article	Year
Measuring lidocaine metabolite--monoethylglycinexylidide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosis. Journal of hepatology, 1993, Volume: 19, Issue:1 Topics: Adult; Chronic Disease; Female; Follow-Up Studies; Galactose; Hepatitis; Humans; Indocyanine Green; Lidocaine; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Prognosis; Prospective Studies; Prothrombin Time; Serum Albumin	1993

Article

Year

Measuring lidocaine metabolite--monoethylglycinexylidide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosis.

Journal of hepatology, 1993, Volume: 19, Issue:1

Topics: Adult; Chronic Disease; Female; Follow-Up Studies; Galactose; Hepatitis; Humans; Indocyanine Green; Lidocaine; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Prognosis; Prospective Studies; Prothrombin Time; Serum Albumin

1993

Other Studies

5 other study(ies) available for monoethylglycinexylidide and Hepatitis

Article	Year
Quantitative liver testing with MEG-X: more optimism? Hepatology (Baltimore, Md.), 1995, Volume: 21, Issue:6 Topics: Autoimmune Diseases; Biopsy; Hepatitis; Hepatitis C; Lidocaine; Liver; Reproducibility of Results	1995
Hepatic lidocaine metabolism and liver histology in patients with chronic hepatitis and cirrhosis. Hepatology (Baltimore, Md.), 1994, Volume: 19, Issue:4 Topics: Adult; Aged; Alanine Transaminase; Chronic Disease; Female; Hepatitis; Humans; Lidocaine; Liver; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Sensitivity and Specificity	1994
Hepatic lidocaine metabolism is useful in the selection of patients in need of liver transplantation. Transplantation proceedings, 1993, Volume: 25, Issue:1 Pt 2 Topics: Hepatitis; Humans; Lidocaine; Liver; Liver Cirrhosis; Liver Diseases; Liver Transplantation	1993
Oral or intravenous lidocaine administration to perform megx test? Digestive diseases and sciences, 2000, Volume: 45, Issue:5 Topics: Administration, Oral; Diagnosis, Differential; Hepatitis; Humans; Infusions, Intravenous; Lidocaine; Liver Cirrhosis; Liver Function Tests; Predictive Value of Tests	2000
Reassessment of monoethylglycinexylidide as preoperative liver function test in a rat model of liver cirrhosis and man. Clinical and experimental medicine, 2001, Volume: 1, Issue:1 Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Bilirubin; Disease Models, Animal; Hepatectomy; Hepatitis; Hepatitis C, Chronic; Humans; Indicators and Reagents; Indocyanine Green; Lidocaine; Liver; Liver Cirrhosis; Liver Cirrhosis, Experimental; Liver Function Tests; Male; Organic Chemicals; Prothrombin Time; Rats; Rats, Wistar; Regression Analysis; Serum Albumin; Thioacetamide	2001